AstraZeneca Stock and Partner Ionis Sink After Trial Failure. Alnylam Soars.

Barrons Barrons —

AstraZeneca and California-based biotech Ionis Pharmaceuticals announce a late-stage trial failure for their gene silencing drug, Wainua.

Read full article at Barrons →